Precision oncology: Diagnosis and treatment of TRK fusion-positive GI cancers

December 06, 2023 00:18:01
Precision oncology: Diagnosis and treatment of TRK fusion-positive GI cancers
COR2ED - Oncology Medical Conversation
Precision oncology: Diagnosis and treatment of TRK fusion-positive GI cancers

Dec 06 2023 | 00:18:01

/

Show Notes

In this podcast, PO CONNECT members Prof Frédérique Penault-Llorca (University of Clermont-Ferrand, France) and Prof Andrea Sartore-Bianchi (Niguarda Cancer Centre, Milan, Italy) provide both a pathologist and medical oncologist perspective about the detection and treatment of TRK fusion-positive GI cancers, with a particular focus on colorectal cancer.

Penault-Llorca and Sartore-Bianchi start by explaining TRK fusion biology, the role as oncogenic drivers and briefly describe the two approved TRK inhibitors. They then discuss the challenges of finding patients harboring these fusions, referring to how enrichment strategies and predictors can aid identification in patients with GI cancers. Finally, they discuss key efficacy and safety data for larotrectinib and entrectinib, as well as mentioning second-generation products in development to tackle mechanisms of resistance.

Other Episodes

Episode

December 06, 2023 00:25:18
Episode Cover

Upper GI cancer Highlights from ASCO GI 2023 - Part 1

This episode, covers the highlights on gastroesophageal, gastric and gastroesophageal junction (GEJ) cancer from ASCO GI 2023.  Dr Nataliya Uboha (University of Wisconsin, USA)...

Listen

Episode

December 06, 2023 00:21:50
Episode Cover

Prostate cancer: PARP inhibitors. Part 1 - PARPi monotherapy; US and EU perspectives

Dr Neal Shore, Uro-Oncologist and Chief Medical Officer for Genesis Care and Urology and Surgical Oncology in the United States and Dr Elena Castro,...

Listen

Episode

December 06, 2023 00:12:16
Episode Cover

HCC: Highlights from ASCO and WCGIC 2021

In this episode, Dr Choo discusses some key abstracts presented during the virtual ASCO and WCGIC congresses in 2021. Dr Choo comments that despite...

Listen